Fredag 28 November | 09:33:48 Europe / Stockholm

Kalender

Est. tid*
2026-05-22 N/A Årsstämma
2026-02-20 12:10 Bokslutskommuniké 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-29 - Kvartalsrapport 2025-Q2
2025-05-26 - X-dag ordinarie utdelning SDET 0.00 SEK
2025-05-23 - Årsstämma
2025-04-30 - Kvartalsrapport 2025-Q1
2025-02-21 - Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-08-21 - Extra Bolagsstämma 2024
2024-05-27 - X-dag ordinarie utdelning SDET 0.00 SEK
2024-05-24 - Årsstämma
2024-05-24 - Kvartalsrapport 2024-Q1
2024-02-22 - Bokslutskommuniké 2023
2023-11-30 - Extra Bolagsstämma 2023
2023-11-06 - Kvartalsrapport 2023-Q3
2023-08-28 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning SDET 0.00 SEK
2023-05-25 - Årsstämma
2023-05-25 - Kvartalsrapport 2023-Q1
2023-02-24 - Bokslutskommuniké 2022
2022-11-11 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-08 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-05-19 - X-dag ordinarie utdelning SDET 0.00 SEK
2022-02-25 - Bokslutskommuniké 2021
2021-11-23 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-20 - Kvartalsrapport 2021-Q1
2021-05-04 - X-dag ordinarie utdelning SDET 0.00 SEK
2021-05-03 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-11-27 - Kvartalsrapport 2020-Q3
2020-08-28 - Kvartalsrapport 2020-Q2
2020-06-30 - X-dag ordinarie utdelning SDET 0.00 SEK
2020-06-29 - Årsstämma
2020-05-04 - Kvartalsrapport 2020-Q1
2020-02-17 - Bokslutskommuniké 2019
2019-11-11 - Kvartalsrapport 2019-Q3
2019-08-19 - Kvartalsrapport 2019-Q2
2019-08-15 - Extra Bolagsstämma 2019
2019-05-13 - Kvartalsrapport 2019-Q1
2019-05-03 - X-dag ordinarie utdelning SDET 0.00 SEK
2019-05-02 - Årsstämma
2019-02-12 - Bokslutskommuniké 2018
2018-11-12 - Kvartalsrapport 2018-Q3
2018-08-20 - Kvartalsrapport 2018-Q2
2018-05-11 - Kvartalsrapport 2018-Q1
2018-05-03 - X-dag ordinarie utdelning SDET 0.00 SEK
2018-05-02 - Årsstämma
2018-02-19 - Bokslutskommuniké 2017
2017-11-13 - Kvartalsrapport 2017-Q3
2017-08-21 - Kvartalsrapport 2017-Q2
2017-05-16 - X-dag ordinarie utdelning SDET 0.00 SEK
2017-05-15 - Årsstämma
2017-05-12 - Kvartalsrapport 2017-Q1
2017-02-20 - Bokslutskommuniké 2016
2016-11-14 - Kvartalsrapport 2016-Q3
2016-08-22 - Kvartalsrapport 2016-Q2
2016-06-20 - X-dag ordinarie utdelning SDET 0.00 SEK
2016-06-17 - Årsstämma
2016-05-19 - Kvartalsrapport 2016-Q1
2016-02-22 - Bokslutskommuniké 2015
2015-11-16 - Kvartalsrapport 2015-Q3
2015-08-24 - Kvartalsrapport 2015-Q2
2015-06-04 - X-dag ordinarie utdelning SDET 0.00 SEK
2015-06-03 - Årsstämma
2015-05-12 - Kvartalsrapport 2015-Q1
2015-02-26 - Bokslutskommuniké 2014
2014-11-07 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-06-04 - X-dag ordinarie utdelning SDET 0.00 SEK
2014-06-03 - Årsstämma
2014-05-28 - Kvartalsrapport 2014-Q1
2014-02-26 - Bokslutskommuniké 2013
2013-11-21 - Kvartalsrapport 2013-Q3
2013-08-29 - Kvartalsrapport 2013-Q2
2013-06-18 - X-dag ordinarie utdelning SDET 0.00 SEK
2013-06-17 - Årsstämma
2013-05-17 - Kvartalsrapport 2013-Q1
2013-04-03 - 15-7 2013
2013-03-13 - Extra Bolagsstämma 2013
2013-01-28 - Bokslutskommuniké 2012
2012-11-22 - Kvartalsrapport 2012-Q3
2012-08-29 - Kvartalsrapport 2012-Q2
2012-05-23 - Kvartalsrapport 2012-Q1
2012-03-08 - X-dag ordinarie utdelning SDET 0.00 SEK
2012-03-07 - Årsstämma
2012-02-06 - Bokslutskommuniké 2011
2011-11-24 - Kvartalsrapport 2011-Q3
2011-08-25 - Kvartalsrapport 2011-Q2
2011-05-13 - X-dag ordinarie utdelning SDET 0.00 SEK
2011-05-12 - Årsstämma
2011-05-05 - Kvartalsrapport 2011-Q1
2011-02-07 - Bokslutskommuniké 2010
2010-05-07 - X-dag ordinarie utdelning SDET 0.00 SEK

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
SensoDetect är verksamt inom hälsovårdssektorn. Bolaget är specialiserat inom utveckling av medicinsk utrustning som används för att analysera hur en patients hjärna reagerar på ljudstimulans. Tekniken används inom psykiatrin för att urskilja potentiella psykiska sjukdomar. Produkten består av elektroder som fästs på patientens huvud som sedan analyserar hjärnaktiviteten. Resultaten jämförs mot en databas för vidare analys. SensoDetect grundades 2005 och har sitt huvudkontor i Lund.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2025-11-26 10:44:57

SensoDetect AB today addresses recent share-price volatility and reaffirms the Company's accelerating execution, strengthening market position and increasingly favourable financial trajectory. The Company emphasises that the recent movement in share price stands in stark contrast to the strategic and operational progress being achieved across China, Saudi Arabia and Sweden.

-----------------------------------------------------------------------------------------------------------------------------------------------

Execution is accelerating across core markets

 

Over recent months, SensoDetect has materially strengthened its operational platform and commercial readiness by

  • activating the AI-enhanced BERA platform within the China JV,
  • advancing structured cooperation with hospitals, schools, universities and industry groups,
  • preparing the JV-built prototype for transfer to Sweden for final AI integration,
  • elevating engagement with national health leadership in Saudi Arabia,
  • and consolidating Sweden's central role as the Company's global AI & quality hub.

 

These developments significantly elevate SensoDetect's market readiness and commercial potential heading into 2026.

-----------------------------------------------------------------------------------------------------------------------------------------------

China - positioned for structured scale

 

The Company's China strategy is now moving from foundation to controlled acceleration.

 

Core pillars now advancing

  • prototype transfer to Sweden for calibration & AI upgrade,
  • expansion of clinical partnerships across regions,
  • deepening cooperation with private school systems,
  • structured dialogues with industrial partners incl. aviation & security,
  • and the establishment of AI collaboration with leading universities.

 

The Company's leadership in China underscores confidence, momentum and strategic alignment.

-----------------------------------------------------------------------------------------------------------------------------------------------

Saudi Arabia - progressing toward national deployment

 

Discussions with leading healthcare authorities in Saudi Arabia are progressing with a shared strategic objective

  • to enable structured, nationwide, objective neurodevelopmental screening.

 

SensoDetect views Saudi Arabia as a central market within its global scale strategy.

-----------------------------------------------------------------------------------------------------------------------------------------------

Financial trajectory strengthening

 

SensoDetect continues to execute with a strict performance-driven financial philosophy based on

  • disciplined cost structure,
  • expanding partnership-based revenue,
  • and increasing operational throughput.

 

Internal modeling signals a strengthening financial trend-line into 2026, with momentum expected to increase further into 2027.

-----------------------------------------------------------------------------------------------------------------------------------------------

 

CEO Statement - PA Hedin

 

"We are executing a very clear strategy. While the market has been volatile in the short term, our direction, our milestones, and our momentum have never been clearer. Across China, Saudi Arabia and Sweden, SensoDetect is building a scalable, high-integrity commercial platform. 2026 is designed as the year where structures convert into commercial outcomes, and 2027 is designed as the acceleration phase. I want to thank our long-term shareholders for their confidence. We are entering this next phase determined, focused and with a long-term mindset."

-----------------------------------------------------------------------------------------------------------------------------------------------

Forward direction

 

SensoDetect is sharply focused on executing the next phase of its growth plan:

  • accelerated implementation in China,
  • structured deployment in Saudi Arabia,
  • strengthened global AI & quality function in Sweden,
  • disciplined scale-up toward commercial inflection.

 

SensoDetects management firmly believes the Company's fundamental value will become increasingly visible as these initiatives convert into measurable commercial progress.